CN103254283A - 一种微管蛋白聚合剂多肽及其应用 - Google Patents
一种微管蛋白聚合剂多肽及其应用 Download PDFInfo
- Publication number
- CN103254283A CN103254283A CN2013102088686A CN201310208868A CN103254283A CN 103254283 A CN103254283 A CN 103254283A CN 2013102088686 A CN2013102088686 A CN 2013102088686A CN 201310208868 A CN201310208868 A CN 201310208868A CN 103254283 A CN103254283 A CN 103254283A
- Authority
- CN
- China
- Prior art keywords
- tubulin
- application
- tubulin polymerization
- polymerization agent
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 24
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 24
- 102000004243 Tubulin Human genes 0.000 title abstract description 20
- 108090000704 Tubulin Proteins 0.000 title abstract description 20
- 230000000379 polymerizing effect Effects 0.000 title abstract description 7
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 9
- MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 claims description 28
- 239000012985 polymerization agent Substances 0.000 claims description 23
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 13
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000004083 survival effect Effects 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 239000003795 chemical substances by application Substances 0.000 abstract description 7
- 238000006116 polymerization reaction Methods 0.000 abstract description 6
- 241000699670 Mus sp. Species 0.000 abstract description 3
- 238000009509 drug development Methods 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 239000002547 new drug Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 102000029749 Microtubule Human genes 0.000 description 10
- 108091022875 Microtubule Proteins 0.000 description 10
- 210000004688 microtubule Anatomy 0.000 description 10
- 229930012538 Paclitaxel Natural products 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 229960001592 paclitaxel Drugs 0.000 description 9
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000013016 damping Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004992 fission Effects 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JVWPPCWUDRJGAE-YUMQZZPRSA-N Gly-Asn-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JVWPPCWUDRJGAE-YUMQZZPRSA-N 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 1
- 101710141955 RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 description 1
- 102000009270 Tumour necrosis factor alpha Human genes 0.000 description 1
- 108050000101 Tumour necrosis factor alpha Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000036815 beta tubulin Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 210000000448 cultured tumor cell Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000029115 microtubule polymerization Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000031877 prophase Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- -1 taxol are arranged Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310208868.6A CN103254283B (zh) | 2013-05-30 | 2013-05-30 | 一种微管蛋白聚合剂多肽及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310208868.6A CN103254283B (zh) | 2013-05-30 | 2013-05-30 | 一种微管蛋白聚合剂多肽及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103254283A true CN103254283A (zh) | 2013-08-21 |
CN103254283B CN103254283B (zh) | 2014-08-06 |
Family
ID=48958536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310208868.6A Active CN103254283B (zh) | 2013-05-30 | 2013-05-30 | 一种微管蛋白聚合剂多肽及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103254283B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101812127A (zh) * | 2009-02-19 | 2010-08-25 | 中国科学技术大学 | 微管结合蛋白及其编码基因与应用 |
-
2013
- 2013-05-30 CN CN201310208868.6A patent/CN103254283B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101812127A (zh) * | 2009-02-19 | 2010-08-25 | 中国科学技术大学 | 微管结合蛋白及其编码基因与应用 |
Non-Patent Citations (2)
Title |
---|
吴作基等: "微管解聚相关蛋白质Kinesin-13、Stathmin和Katanin", 《生命科学》 * |
尚海等: "微管蛋白抑制剂的研究进展", 《药学学报》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103254283B (zh) | 2014-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103254281B (zh) | 一种微管蛋白聚合剂多肽6及其应用 | |
CN103254287A (zh) | 一种微管蛋白解聚剂多肽及其应用 | |
CN103288926B (zh) | 一种微管蛋白聚合剂多肽及其应用 | |
CN103254283B (zh) | 一种微管蛋白聚合剂多肽及其应用 | |
CN103265621B (zh) | 一种微管蛋白解聚剂多肽及其应用 | |
CN103254282B (zh) | 一种微管蛋白解聚剂多肽5及其应用 | |
CN103923184A (zh) | 一种粘附斑激酶抑制剂多肽及其应用 | |
CN103739680B (zh) | 一种抑制粘附斑激酶多肽及其应用 | |
CN103304632A (zh) | 一种微管蛋白聚合剂多肽2及其应用 | |
CN103304633A (zh) | 一种微管蛋白聚合剂多肽1及其应用 | |
CN103254284B (zh) | 一种微管蛋白解聚剂多肽及其应用 | |
CN103254289B (zh) | 一种微管蛋白解聚剂多肽及其应用 | |
CN103739678B (zh) | 抑制粘附斑激酶多肽及其应用 | |
CN103923187A (zh) | 一种粘附斑激酶抑制剂多肽及其应用 | |
CN103923173A (zh) | 一种聚乙二醇修饰的微管蛋白聚合剂多肽及其应用 | |
Zheng et al. | Effects of Cells Self-aggregation in the Treatment of Neurogenic Erectile Dysfunction With Traditional Single Cell Suspension of Adipose-derived Stem Cells | |
CN103923179A (zh) | 一种粘附斑激酶抑制剂多肽及其应用 | |
CN104045689B (zh) | 一种关于生长抑素受体激动剂多肽及其应用 | |
CN103923170A (zh) | 一种聚乙二醇修饰的微管蛋白解聚剂多肽及其应用 | |
CN104694520A (zh) | 一种水解纤维蛋白溶酶原多肽及其应用 | |
Alkan et al. | Strategic and Innovative Roles of lncRNAs Regulated by Naturally-Derived Small Molecules in Cancer Therapy | |
CN103877072B (zh) | 一种预防或治疗神经胶质瘤的药物组合物及其用途 | |
CN104017052B (zh) | 关于Npas2蛋白激动剂多肽及其应用 | |
CN111150721A (zh) | 一种钙调蛋白磷酸酶抑制剂及其在抗肿瘤中应用 | |
CN106749549A (zh) | Myc癌基因抑制多肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XIAMEN OURUIJIE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SUZHOU PULUODA BIOLOG SCIENCE + TECHNOLOGY CO., LTD. Effective date: 20140715 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215000 SUZHOU, JIANGSU PROVINCE TO: 361000 XIAMEN, FUJIAN PROVINCE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140715 Address after: 361000, Fujian province Xiamen torch hi tech Zone (Xiangan) Industrial Zone Jianye Building, block D, Room 502 and 504 Applicant after: XIAMEN OURUIJIE BIOTECHNOLOGY CO.,LTD. Address before: High tech Zone Suzhou city Jiangsu province 215000 Chuk Yuen Road No. 209 Applicant before: SUZHOU PULUODA BIOLOGICAL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A tubulin polymeric peptide and its application Effective date of registration: 20201225 Granted publication date: 20140806 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980009948 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231026 Granted publication date: 20140806 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY CO.,LTD. Registration number: Y2020980009948 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Microtubulin Polymerizing Agent Peptide and Its Application Effective date of registration: 20231031 Granted publication date: 20140806 Pledgee: Bank of China Limited Xiamen Xiang'an sub branch Pledgor: XIAMEN OURUIJIE BIOTECHNOLOGY CO.,LTD. Registration number: Y2023980063461 |